Company record · MCRB
Seres Therapeutics, Inc.
Seres Therapeutics, Inc. disclosed a change in its chief financial officer, effective November 15, 2026. Until then the filing lists Marella Thorell in the role. See the filing record.
The record holds 1 verified CFO change for Seres Therapeutics, Inc. from Form 8-K filings, filed October 26, 2026.
The CFO seat
Computed from the records below: a move filed on or after the 10-K replaces the 10-K's signature.
| Status | Change pending |
|---|---|
| Officer | Marella Thorell |
| Effective | November 15, 2026 |
| Basis | Latest move: departure, 8-K filed October 26, 2026 |
Seat timeline
1Every verified record for this seat, newest first, dated as the filing states it.
2026-10-26Departure
Seres Therapeutics, Inc. discloses CFO departure: Marella Thorelleffective November 15, 2026 · 8-K filed October 26, 2026 · sec.gov, Item 5.02
Company
| Ticker | MCRB |
|---|---|
| SEC CIK | 0001609809 |
| Industry (SIC) | Not established: the company is not on the roster |
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.